| David M Keuchel, DO | |
|
620 S Madison St, Suite 203, Enid, OK 73701-7273 | |
| (580) 237-7280 | |
| (580) 548-1505 |
| Full Name | David M Keuchel |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 620 S Madison St, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790785202 | NPI | - | NPPES |
| 101137230B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2791 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David M Keuchel, DO Po Box 5038, Enid, OK 73702-5038 Ph: (580) 548-1367 | David M Keuchel, DO 620 S Madison St, Suite 203, Enid, OK 73701-7273 Ph: (580) 237-7280 |
News Archive
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel.
A new study published in Age and Ageing indicates that frail patients in any age group are more likely to die than those who are not frail.
Magellan Health Services, Inc. today reported financial results for the third quarter of 2010, as summarized below, and increased guidance for the full year. For the quarter ended September 30, 2010, the Company reported net revenue of $750.3 million, segment profit of $90.1 million, and net income of $44.8 million or $1.31 per diluted common share.
Obesity is among the most common complex diseases in the United States and has been a stubborn public health challenge for decades. Its causes are wide ranging, but genetic heritability is increasingly understood to be an influential factor in determining a person's risk for the disease.
› Verified 8 days ago
Dr. Michael S Jackson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 620 S Madison St Ste 304, Enid, OK 73701 Phone: 580-233-6350 Fax: 580-233-6106 | |
David D Parker, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 615 E Oklahoma Ave, Suite 203, Enid, OK 73701 Phone: 580-242-3870 Fax: 580-242-4046 | |
David L Weaver Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 W Garriott Rd, Enid, OK 73701 Phone: 580-977-1903 Fax: 580-548-1434 | |
Michelle R Bergner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 W Garriott Rd, Enid, OK 73701 Phone: 580-233-1100 Fax: 580-548-1434 | |
Dr. Christopher Marcus Lee, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 615 E Oklahoma Ave Ste 203, Enid, OK 73701 Phone: 580-242-3870 Fax: 580-242-4046 | |
Daniel E Oathout, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 620 S Madison St, Suite 301, Enid, OK 73701 Phone: 580-233-6350 Fax: 580-233-6106 |